DHC CEO granted 12,401 shares in equity award

Bilotto Christopher J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bilotto Christopher J. reported acquisition or exercise transactions in this Form 4 filing.

Diversified Healthcare Trust President and CEO Christopher J. Bilotto received an award of 12,401 Common Shares of Beneficial Interest on June 10, 2026 at no cash cost, as part of the company’s equity compensation plan. After this grant and shares added through a dividend reinvestment plan, his direct holdings total about 279,246.802 shares, including 560.894 shares accumulated from reinvested dividends since his last ownership report.

Insider Trade Summary

Grant/Award: 12,401 shares

Grant/Award 1 txn

Insider Bilotto Christopher J.

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Shares of Beneficial Interest	12,401	$0.00	$0.00

Holdings After Transaction: Common Shares of Beneficial Interest — 279,246.802 shares (Direct)

Footnotes (2)

1. F1. Transaction reported is award of shares pursuant to the Issuer's equity compensation plan.
2. F2. Includes 560.894 shares acquired under a dividend reinvestment plan since the last Section 16 filing by Mr. Bilotto.

Key Figures

Equity award shares: 12,401 shares Grant price per share: $0.00 per share Total shares after transaction: 279,246.802 shares +2 more

5 metrics

Equity award shares 12,401 shares Grant of Common Shares of Beneficial Interest on June 10, 2026

Grant price per share $0.00 per share Reported transaction price for the awarded shares

Total shares after transaction 279,246.802 shares Direct holdings following the equity award

Dividend reinvestment shares 560.894 shares Shares acquired under dividend reinvestment plan since last filing

Acquisition transactions 1 transaction Form 4 transactionSummary acquireCount

Key Terms

equity compensation plan, dividend reinvestment plan, Common Shares of Beneficial Interest

3 terms

equity compensation plan financial

"Transaction reported is award of shares pursuant to the Issuer's equity compensation plan."

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

dividend reinvestment plan financial

"Includes 560.894 shares acquired under a dividend reinvestment plan since the last Section 16 filing"

A dividend reinvestment plan lets shareholders automatically use cash dividends to buy more shares of the same company instead of receiving the money. It matters to investors because it turns regular payouts into a steady way to grow ownership and take advantage of compound returns—like having your savings automatically buy additional slices of a pie over time—while often reducing transaction costs and smoothing purchase timing.

Common Shares of Beneficial Interest financial

"security_title: Common Shares of Beneficial Interest"

Common Shares of Beneficial Interest are units that represent ownership in a company or organization, like owning a piece of a pie. They give investors voting rights and a chance to share in profits, making them important for those looking to invest and have a say in how the organization is run.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did DHC President and CEO Christopher Bilotto report?

Christopher Bilotto reported receiving an award of 12,401 Common Shares of Beneficial Interest in Diversified Healthcare Trust. The shares were granted at no cash cost under the company’s equity compensation plan, reflecting routine stock-based compensation rather than an open-market share purchase.

How many DHC shares does Christopher Bilotto hold after this Form 4 transaction?

After the reported award, Christopher Bilotto directly holds a total of 279,246.802 Diversified Healthcare Trust common shares. This figure includes additional shares accumulated through a dividend reinvestment plan since his last Section 16 filing, as disclosed in the Form 4 footnotes.

Was Christopher Bilotto’s DHC share award an open-market purchase?

No, the 12,401 Diversified Healthcare Trust shares were granted to Christopher Bilotto under the issuer’s equity compensation plan at a reported price of $0.00 per share. This indicates a compensation-related stock award rather than an open-market purchase transaction by the executive.

What does the dividend reinvestment plan disclosure mean for DHC insider holdings?

The footnote states that Bilotto’s holdings include 560.894 shares acquired under a dividend reinvestment plan since his last filing. This means cash dividends on existing DHC shares were automatically used to buy additional shares, modestly increasing his direct ownership over time.

How is the Form 4 transaction by DHC’s CEO classified by the SEC code?

The transaction is coded “A” on Form 4, described as a grant, award, or other acquisition. In this case, it reflects an equity compensation grant of 12,401 Diversified Healthcare Trust common shares to CEO Christopher Bilotto, rather than a market trade or option exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/12/2026 - 04:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bilotto Christopher J.

(Last) (First) (Middle)

C/O THE RMR GROUP LLC

TWO NEWTON PL., 255 WASH. ST., STE. 300

(Street)

NEWTON MASSACHUSETTS 02458

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DIVERSIFIED HEALTHCARE TRUST [ NASDAQ:DHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares of Beneficial Interest	06/10/2026		A		12,401	A	(1)	279,246.802(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction reported is award of shares pursuant to the Issuer's equity compensation plan.

2. Includes 560.894 shares acquired under a dividend reinvestment plan since the last Section 16 filing by Mr. Bilotto.

	/s/ Christopher J. Bilotto	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)